These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 27743816)

  • 41. Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial.
    Antonsen L; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Kaltoft A; Hansen HS; Thuesen L; Lassen JF; Jensen LO
    Catheter Cardiovasc Interv; 2014 May; 83(6):864-72. PubMed ID: 23996918
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optical coherence tomography findings in lesions after sirolimus-eluting stent implantation with peri-stent contrast staining.
    Tada T; Kadota K; Hosogi S; Kubo S; Ozaki M; Yoshino M; Miyake K; Eguchi H; Ohashi N; Hayakawa Y; Saito N; Otsuru S; Hasegawa D; Shigemoto Y; Habara S; Imai M; Tanaka H; Fuku Y; Oka N; Kato H; Yamamoto H; Fujii S; Goto T; Mitsudo K
    Circ Cardiovasc Interv; 2012 Oct; 5(5):649-56. PubMed ID: 23011265
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plaque Morphology Predictors of Side Branch Occlusion After Main Vessel Stenting in Coronary Bifurcation Lesions: Optical Coherence Tomography Imaging Study.
    Kini AS; Yoshimura T; Vengrenyuk Y; Amirian J; Hasan C; Baber U; Narula J; Sharma SK
    JACC Cardiovasc Interv; 2016 Apr; 9(8):862-865. PubMed ID: 27101914
    [No Abstract]   [Full Text] [Related]  

  • 44. Complex, diffuse in-stent atherosclerosis over a decade following bare metal stenting.
    Lau JK; Alcock RF; Brieger D; Lowe HC
    Coron Artery Dis; 2015 Aug; 26 Suppl 1():e69-70. PubMed ID: 26247273
    [No Abstract]   [Full Text] [Related]  

  • 45. Use of the Crossboss catheter in coronary chronic total occlusion due to in-stent restenosis.
    Papayannis A; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2012 Aug; 80(2):E30-6. PubMed ID: 22162302
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
    Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optical coherence tomography-based predictors for creatine kinase-myocardial band elevation after elective percutaneous coronary intervention for in-stent restenosis.
    Lee SY; Hong MK; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y
    Catheter Cardiovasc Interv; 2015 Mar; 85(4):564-72. PubMed ID: 25158217
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).
    Ribichini F; Romano M; Rosiello R; La Vecchia L; Cabianca E; Caramanno G; Milazzo D; Loschiavo P; Rigattieri S; Musarò S; Pironi B; Fiscella A; Amico F; Indolfi C; Spaccarotella C; Bartorelli A; Trabattoni D; Della Rovere F; Rolandi A; Beqaraj F; Belli R; Sangiorgio P; Villani R; Berni A; Sheiban I; Lopera Quijada MJ; Cappi B; Ribaldi L; Vassanelli C;
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1012-22. PubMed ID: 24055444
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Percutaneous coronary intervention for a right coronary artery stent occlusion using retrograde delivery of a sirolimus-eluting stent via a septal perforator.
    Utunomiya M; Katoh O; Nakamura S
    Catheter Cardiovasc Interv; 2009 Mar; 73(4):475-80. PubMed ID: 19229979
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Optical coherence tomography characteristics of in-stent restenosis after drug-eluting stent implantation: a novel classification and its clinical significance.
    Yamamoto W; Fujii K; Otsuji S; Takiuchi S; Kakishita M; Ibuki M; Hasegawa K; Ishibuchi K; Tamaru H; Yasuda S; Ishii R; Nakabayashi S; Kusumoto H; Higashino Y
    Heart Vessels; 2020 Jan; 35(1):38-45. PubMed ID: 31250131
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of In-Stent Restenosis: When the Stent Is No Longer There.
    Antuña P; Cuesta J; García-Guimaraes M; Bastante T; De Rueda C; Rivero F; Alfonso F
    JACC Cardiovasc Interv; 2020 Apr; 13(7):e53-e55. PubMed ID: 31883713
    [No Abstract]   [Full Text] [Related]  

  • 52. Restenosis After Drug-Eluting Stent Implantation in a Patient With Polycythemia Vera: Optical Coherence Tomography and Pathological Findings.
    Fujino A; Hao H; Kajimoto N; Kawakami R; Imanaka T; Fujii K; Abe T; Ishihara M; Hirota S
    JACC Cardiovasc Interv; 2015 Jun; 8(7):e111-2. PubMed ID: 26003023
    [No Abstract]   [Full Text] [Related]  

  • 53. Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography.
    Li S; Gai L; Yang T; Zhang L; Xu X; Bai Q; Xu H; Wang Y
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):768-75. PubMed ID: 22639418
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nine-month angiographic and 2-year clinical follow-up of the NOYA biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the NOYA I trial.
    Xu B; Dou K; Yang Y; Lv S; Wang L; Wang H; Li Z; Wang L; Chen Y; Huo Y; Li W; Kirtane AJ; Gao R
    EuroIntervention; 2012 Nov; 8(7):796-802. PubMed ID: 23171800
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intra-stent tissue evaluation within bare metal and drug-eluting stents > 3 years since implantation in patients with mild to moderate neointimal proliferation using optical coherence tomography and virtual histology intravascular ultrasound.
    Kitabata H; Loh JP; Pendyala LK; Omar A; Ota H; Minha S; Magalhaes MA; Torguson R; Chen F; Satler LF; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2014 Apr; 15(3):149-55. PubMed ID: 24767313
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metal allergy to everolimus-eluting cobalt chromium stents confirmed by positive skin testing as a cause of recurrent multivessel in-stent restenosis.
    Nakajima Y; Itoh T; Morino Y
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):E137-42. PubMed ID: 26011018
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optical coherence tomography to evaluate coronary stent implantation and complications.
    Hayat U; Thondapu V; Ul Haq MA; Foin N; Jang IK; Barlis P
    Coron Artery Dis; 2015 Aug; 26 Suppl 1():e55-68. PubMed ID: 26247272
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unusually aggressive immature neo-intimal hyperplasia causing in-stent restenosis.
    McCutcheon K; Triantafyllis AS; Bennett J; Adriaenssens T
    Cardiovasc J Afr; 2017 Nov/Dec 23; 28(6):404-405. PubMed ID: 29019519
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An Impressive Case of "Honeycomb" In-Stent Restenosis.
    Lorenzoni G; Merella P; Viola G; Marziliano N; Casu G
    J Invasive Cardiol; 2018 Sep; 30(9):E99. PubMed ID: 30158330
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Unfavorable bioresorbable vascular scaffold resorption, a cause of restenosis?
    Ishida K; Giacchi G; Brugaletta S; García-Álvarez A; Sabaté M
    Cardiovasc Revasc Med; 2016 Dec; 17(8):571-573. PubMed ID: 27345841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.